Barinthus Biotherapeutics BRNS Cash Flow Statement (2020-2026)

NASDAQ BRNS
$0.61 +0.01 (+1.67%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-7.04M-16.82M2.57M15.69M8.22M-21.16M-18.22M-23.82M-14.11M-17.29M-15.52M-16.94M-8.13M-20.59M-19.66M-21.13M-14.57M-11.10M-5.53M-10.60M
Depreciation and Depletion (Quarter)
0.20M0.20M0.40M0.30M0.40M0.50M0.70M0.70M0.60M0.70M0.70M0.60M1.20M1.20M0.10M0.30M0.20M0.20M
Share-based Compensation (Quarter)
3.37M3.58M3.98M2.75M8.70M7.48M2.22M1.99M0.06M0.79M1.61M1.20M1.14M0.76M0.47M-0.28M-0.41M0.70M0.56M0.43M
Deferred Taxes (Quarter)
-0.03M-0.06M-0.86M-0.92M-0.62M-1.93M-0.52M-1.14M-0.60M-0.82M-0.04M-0.01M-0.00M0.00M-0.02M-0.03M-0.07M-0.06M-0.02M-0.02M
Gains from Investment Securities (Quarter)
0.14M0.48M0.32M-1.02M0.09M0.22M-0.22M-0.03M0.06M0.02M-0.38M1.17M0.00M-0.34M0.02M0.35M0.08M0.09M
Asset Writedowns and Impairment (Quarter)
5.26M4.67M1.13M
Cash from Operations (Quarter)
-2.02M-7.97M-6.58M-8.39M11.88M-11.34M-3.17M-16.96M-11.19M-19.60M-11.82M-12.01M-18.20M13.09M-14.90M-18.11M-10.73M-4.24M-3.37M-8.09M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.09M0.32M0.97M0.99M1.19M1.18M1.22M1.30M1.47M1.44M1.43M1.47M1.48M1.43M2.03M2.00M0.90M0.91M0.86M0.82M
Change in Working Capital
Change in Receivables (Quarter)
0.01M-0.07M18.35M-1.32M-10.87M-0.33M-4.96M-0.65M-0.19M
Change in Account Payables (Quarter)
-1.87M-0.11M1.74M-0.96M-0.63M1.00M-1.71M-0.21M2.33M-3.79M-0.52M1.49M0.39M-0.46M-1.16M0.34M-1.04M-0.35M0.64M-0.45M
Change in Accured Expenses (Quarter)
1.08M2.57M2.83M-3.32M5.55M-4.32M-1.31M1.59M4.96M-3.24M-0.82M1.96M-2.67M1.98M-2.52M-0.24M-0.57M-0.45M2.59M0.10M
Other Working Capital Changes (Quarter)
-0.02M-0.01M-0.01M-0.01M-0.01M0.04M-0.45M-0.35M-0.47M-0.49M-0.48M-0.48M-0.49M-0.50M-0.50M-0.35M-0.96M
Investing Activities
Capital Expenditures (Quarter)
0.71M0.42M1.36M1.78M2.41M-4.99M2.51M-2.00M5.06M-5.48M0.31M0.19M0.11M0.28M0.01M0.03M
Sales of Property, Plant and Equipment (Quarter)
0.37M0.05M0.06M0.10M
Cash from Investing Activities (Quarter)
-0.13M-12.19M-1.09M-2.05M-2.02M-0.59M-2.51M-3.02M-0.04M0.15M-0.31M-0.19M-0.11M-0.28M-0.01M-0.03M0.45M0.00M0.06M0.06M
Financing Activities
Other financing activities (Quarter)
-0.29M0.00M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Short-Term Debt issuances (Quarter)
0.16M
Change in Capital Stock
Shares Issued (Quarter)
3.36M0.80M4.81M4.94M4.98M1.48M6.81M6.78M6.39M
Net Equity Issued and Repurchased (Quarter)
1.79M0.09M0.05M0.11M0.50M0.36M0.47M0.84M
Misc.
Cash from Financing Activities (Quarter)
-1.39M0.01M-0.16M0.48M1.69M0.03M0.05M0.11M0.50M0.36M0.47M0.84M0.00M
Exchange Rate Effect (Quarter)
-6.21M0.34M-5.63M2.18M-2.09M5.73M0.94M1.65M-1.54M1.12M-0.49M-0.36M6.17M-7.35M3.08M5.35M-1.83M0.42M-1.35M0.47M
Change in Cash (Quarter)
-9.75M-19.82M-13.46M-8.27M7.78M-5.72M-3.06M-18.30M-12.72M-18.22M-12.12M-12.20M-11.67M6.30M-11.82M-12.79M-12.11M-3.82M-4.66M-7.56M
Free Cash Flow (Quarter)
-2.73M-8.40M-7.94M-10.17M9.48M-6.35M-5.68M-14.96M-16.25M-14.12M-12.13M-12.20M-18.31M12.81M-14.91M-18.14M-10.73M-4.24M-3.37M-8.09M
Net Cash Flow (Quarter)
-3.53M-20.15M-7.83M-10.45M9.87M-11.45M-3.99M-19.95M-11.18M-19.34M-11.63M-11.84M-17.85M13.64M-14.90M-18.14M-10.28M-4.24M-3.31M-8.03M